GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹ २,६७९.९०
arrow_upward
+१.०६%(+२८.२०) 1D
नोभेम्बर १७, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹ २,६६७.००
High
₹ २,७२१.८०
Low
₹ २,६६३.७०
Mkt. cap
४.५३ खरब
Avg. vol.
८९.३८ हजार
Volume
७३.९८ हजार
Dividend
२.१३%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.५९
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
Open
₹ २,६६७.००
High
₹ २,७२१.८०
Low
₹ २,६६३.७०
Mkt. cap
४.५३ खरब
Avg. vol.
८९.३८ हजार
Volume
७३.९८ हजार
Dividend
२.१३%
Quarterly dividend
₹ १४.२५
Ex-dividend date
२०२६ मे २९
P/E ratio
३९.५९
52-wk high
₹ ३,१२०.७०
52-wk low
₹ २,०८८.१०
EPS
₹ ६७.६८
Shares outstanding
१६.९४ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
BigGo Finance
·
२७ मिनेट पहिले
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
TV News Check
·
५८ मिनेट पहिले
Dow Drops 849, Nasdaq Sinks 181, S&P 500 Falls 76
marketscreener.com
·
१ घण्टा पहिले
S&P 500 Pullback Extends to Fourth Day Ahead of Nvidia's Earnings
Traders Union
·
१ घण्टा पहिले
Ryan Detrick: Technology stocks outperformed S&P 500 while 75 stocks declined
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees३.१ हजार
Founded१९२४ नोभेम्बर १३
Headquarters-
SectorHealth Care
Industry-
Websiteindia-pharma.gsk.com